プロテオミクスの技術と世界市場

Proteomics: Technologies and Global Markets

プロテオミクスの技術と世界市場

商品番号 : SMB-25116

出版社BCC Research
出版年月2025年5月
ページ数153
価格タイプシングルユーザライセンス
価格USD 4,650
種別英文調査報告書

本レポートは、プロテオーム技術の世界市場における動向を分析しています。2024年を基準年とする世界市場収益(百万ドル)、2025年の予測、そして2025年から2030年までの予測が含まれています。市場は、製品タイプ、用途、プラットフォーム、地域ごとにセグメント化されています。タンパク質構造解析およびタンパク質発現製品は、

本レポートの対象外です。製品タイプには、機器とソフトウェア、消耗品が含まれます。プラットフォームには、質量分析法とバイオチップが含まれます。用途には、創薬・開発、研究、診断、応用プロテオミクスが含まれます。

地域は、北米、ヨーロッパ、アジア太平洋、その他地域(RoW)です。北米には、米国、カナダ、メキシコが含まれます。ヨーロッパには、ドイツ、イギリス、イタリア、フランス、スペイン、その他ヨーロッパが含まれ、アジア太平洋には、中国、日本、インド、韓国、その他アジア太平洋地域が含まれます。RoWには、中東・アフリカ(MEA)と南米が含まれます。

Report Highlights

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

プロテオーム技術の世界市場は、2024年に276億ドルと評価されました。2025年から2030年にかけて年平均成長率(CAGR)13.0%で成長し、2025年の310億ドルから2030年末には572億ドルに達すると予測されています。

Report Scope

The report analyzes trends in the global market for proteomic technologies market. It includes global revenues ($ millions) for the base year of 2024, estimates for 2025 and forecasts for 2025 through 2030. The market is segmented by product type, application, platform and region. Protein structural analysis and protein-expression products are outside the scope of the report. Product types include instruments and software, and consumables. Platforms include mass spectrometry and biochip. Applications include drug discovery and development, research, diagnostics, and applied proteomics. Regions are North America, Europe, Asia-Pacific and the Rest of the World (RoW). North America includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. RoW includes the Middle East and Africa (MEA) and South America.

The report focuses on the trends and challenges that affect the market and vendor landscape. It discusses emerging technologies and includes an analysis of the market shares of the leading companies. It offers a chapter on environmental, social, and corporate governance (ESG) developments. Its section on company profiles covers details such as financials, product portfolio, and recent developments.

Report Synopsis

Report MetricsDetails
Base year considered2024
Forecast period considered2025-2030
Base year market size$27.6 Billion
Market size forecast$57.2 Billion
Growth rateCAGR of 13.0% from 2025 to 2030
Units considered$ Millions
Segments coveredBy Platform, Application, Product Type and Region
Regions coveredNorth America, Europe, Asia-Pacific and the Rest of the World (RoW)
Countries coveredU.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, Japan, China, India, South Korea, Rest of Asia-Pacific, and Rest of Europe
Key Market Drivers
  • Increasing investments in R&D.
  • Transition towards personalized medicine.
  • Rising aging population and growing prevalence of chronic diseases.
  • Emerging technologies.
Companies studied
AGILENT TECHNOLOGIES INC.ARRAYIT CORP.
BIO-RAD LABORATORIES INC.BIO-TECHNE
BRUKERCREATIVE PROTEOMICS
DANAHER CORP.JEOL LTD.
MERCK KGAAPROMEGA CORP.
REVVITYSHIMADZU CORP.
STANDARD BIOTOOLSTHERMO FISHER SCIENTIFIC INC.
WATERS CORP.

Report Includes

– 97 data tables and 56 additional tables

– An overview of the global markets for proteomics and related technologies

– Analyses of the global market trends, with historic market revenue data from 2022 to 2024, estimates for 2025 and projected CAGRs through 2030

– Estimates of the actual market size and forecasts for proteomics, and a corresponding market share analysis by platform type, application, product type, and region

– In-depth facts and figures concerning market dynamics, technology advances, new products and applications for proteomics

– Discussion of patents and emerging technologies

– ESG trends in the industry

– Insight into the industry structure for proteomics technologies, competitive aspects of each product segment, companies’ growth strategies, and a company value share analysis

– Updated information on mergers and acquisitions, agreements, partnerships and new products in the global proteomics industry

– Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher, Agilent Technologies Inc., Bruker and Waters Corp.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Overview

Current Market Scenario

Segmental Analysis

Regional Analysis

Emerging Technologies

Conclusion

Chapter 2 Market Overview

Proteomic Technologies

Types of Proteomics

Expression Proteomics

Structural Proteomics

Functional Proteomics

Proteomics Workflow

Macroeconomic Factors Analysis

Porter’s Five Forces Analysis

Bargaining Power of Buyers

Bargaining Power of Suppliers

Threat of Substitute Products or Services

Potential for New Entrants

Industry Competitiveness

Chapter 3 Market Dynamics

Market Dynamics

Market Drivers

Investments in R&D

Transition To Personalized Medicines

Rising Aging Population and the Growing Prevalence of Chronic Diseases

Market Restraints

High Cost of Instruments and Lack of Skilled Workforce

Complexity of Data Analysis

Market Opportunities

Emerging Technologies

Integrative Approaches

Chapter 4 Regulatory Landscape

Regulatory Overview

Regulations in the U.S.

Regulations in Europe

Proteomics Standards Initiative

Chapter 5 Emerging Technologies and Developments

Emerging Technologies in the Proteomics Market

Advances in Mass Spectrometry

Immuno-Ligation

Single-cell Proteomics

Application of AI in Proteomics

Patent Analysis

Patents, by Top Applicants

Patents, by Assignee Country/Region

Patents, by Year

Key Takeaways

Chapter 6 Market Segmentation Analysis

Overview

Segmentation Breakdown

Market Analysis by Platform Type

Mass Spectrometry

Biochips

Market Analysis by Application

Takeaways

Drug Discovery and Development

Diagnostics

Research

Applied Proteomics

Market Analysis by Product Type

Takeaways

Consumables

Instruments and Software

Geographic Breakdown

Market Analysis by Region

Takeaways

North America

Europe

Asia-Pacific

Rest of the World

Chapter 7 Competitive Intelligence

Overview

Market Ranking Analysis

Strategic Initiatives

Mergers and Acquisitions

Agreements, Collaborations and Partnerships

New Products

Chapter 8 Sustainability in the Proteomics Technology Industry: ESG Perspective

Introduction to Environmental, Social and Governance

Sustainability Trends and Initiatives

Environmental Performance

Social Performance

Governance Performance

ESG Risk Ratings

Concluding Remarks from BCC Research

Chapter 9 Appendix

Methodology

Sources

Abbreviations

Company Profiles

AGILENT TECHNOLOGIES INC.

ARRAYIT CORP.

BIO-RAD LABORATORIES INC.

BIO-TECHNE

BRUKER

CREATIVE PROTEOMICS

DANAHER CORP.

JEOL LTD.

MERCK KGAA

PROMEGA CORP.

REVVITY

SHIMADZU CORP.

STANDARD BIOTOOLS

THERMO FISHER SCIENTIFIC INC.

WATERS CORP.

Emerging Start-ups/Market Disruptors

List of Tables

Summary Table : Global Market for Proteomic Technologies, by Region, Through 2030

Table 1 : Global Incidence and Mortality Rates of Cancer, by Region, 2022

Table 2 : Granted Patents in Proteomics Technologies, 2023–2025

Table 3 : Global Market for Proteomics Technologies, by Platform Type, Through 2030

Table 4 : Global Market for Mass Spectrometry, by Region, Through 2030

Table 5 : Global Market for Biochips, by Type, Through 2030

Table 6 : Global Market for Protein Microarrays, by Array Type, Through 2030

Table 7 : Global Market for Biochips, by Region, Through 2030

Table 8 : Global Market for Proteomic Technologies, by Application Type, Through 2030

Table 9 : Drug Targets Identified by Proteomics

Table 10 : Global Market for Proteomics in Drug Discovery and Development, by Platform Type, Through 2030

Table 11 : Global Market for Proteomics in Drug Discovery and Development, by Region, Through 2030

Table 12 : Examples of LC-MS/MS-based FDA-Approved Tests in Clinical Laboratories

Table 13 : Global Market for Proteomics in Diagnostics, by Platform Type, Through 2030

Table 14 : Global Market for Proteomics in Diagnostics, by Region, Through 2030

Table 15 : Global Market for Proteomics in Diagnostics, by Disease Type, Through 2030

Table 16 : Global Market for Proteomics in Research, by Platform Type, Through 2030

Table 17 : Global Market for Proteomics in Research, by Region, Through 2030

Table 18 : Global Market for Applied Proteomics, by Region, Through 2030

Table 19 : Global Market for Proteomic Technologies, by Product Type, Through 2030

Table 20 : Global Market for Consumables, by Region, Through 2030

Table 21 : Global Market for Instruments and Software, by Region, Through 2030

Table 22 : Global Market for Proteomic Technologies, by Region, Through 2030

Table 23 : North American Market for Proteomic Technologies, by Platform Type, Through 2030

Table 24 : North American Market for Biochips, by Type, Through 2030

Table 25 : North American Market for Proteomic Technologies, by Application Type, Through 2030

Table 26 : North American Market for Proteomic Technologies, by Product Type, Through 2030

Table 27 : North American Market for Proteomic Technologies, by Country, Through 2030

Table 28 : U.S. Market for Proteomic Technologies, by Platform Type, Through 2030

Table 29 : U.S. Market for Proteomic Technologies, by Application Type, Through 2030

Table 30 : U.S. Market for Proteomic Technologies, by Product Type, Through 2030

Table 31 : Canadian Market for Proteomic Technologies, by Platform Type, Through 2030

Table 32 : Canadian Market for Proteomic Technologies, by Application Type, Through 2030

Table 33 : Canadian Market for Proteomic Technologies, by Product Type, Through 2030

Table 34 : Mexican Market for Proteomic Technologies, by Platform Type, Through 2030

Table 35 : Mexican Market for Proteomic Technologies, by Application Type, Through 2030

Table 36 : Mexican Market for Proteomic Technologies, by Product Type, Through 2030

Table 37 : European Market for Proteomic Technologies, by Platform Type, Through 2030

Table 38 : European Market for Biochips, by Type, Through 2030

Table 39 : European Market for Proteomic Technologies, by Application Type, Through 2030

Table 40 : European Market for Proteomic Technologies, by Product Type, Through 2030

Table 41 : European Market for Proteomic Technologies, by Country, Through 2030

Table 42 : German Market for Proteomic Technologies, by Platform Type, Through 2030

Table 43 : German Market for Proteomic Technologies, by Application Type, Through 2030

Table 44 : German Market for Proteomic Technologies, by Product Type, Through 2030

Table 45 : U.K. Market for Proteomic Technologies, by Platform Type, Through 2030

Table 46 : U.K. Market for Proteomic Technologies, by Application Type, Through 2030

Table 47 : U.K. Market for Proteomic Technologies, by Product Type, Through 2030

Table 48 : French Market for Proteomic Technologies, by Platform Type, Through 2030

Table 49 : French Market for Proteomic Technologies, by Application Type, Through 2030

Table 50 : French Market for Proteomic Technologies, by Product Type, Through 2030

Table 51 : Italian Market for Proteomic Technologies, by Platform Type, Through 2030

Table 52 : Italian Market for Proteomic Technologies, by Application Type, Through 2030

Table 53 : Italian Market for Proteomic Technologies, by Product Type, Through 2030

Table 54 : Spanish Market for Proteomic Technologies, by Platform Type, Through 2030

Table 55 : Spanish Market for Proteomic Technologies, by Application Type, Through 2030

Table 56 : Spanish Market for Proteomic Technologies, by Product Type, Through 2030

Table 57 : Rest of European Market for Proteomic Technologies, by Platform Type, Through 2030

Table 58 : Rest of European Market for Proteomic Technologies, by Application Type, Through 2030

Table 59 : Rest of European Market for Proteomic Technologies, by Product Type, Through 2030

Table 60 : Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030

Table 61 : Asia-Pacific Market for Biochips, by Type, Through 2030

Table 62 : Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030

Table 63 : Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030

Table 64 : Asia-Pacific Market for Proteomic Technologies, by Country, Through 2030

Table 65 : Chinese Market for Proteomic Technologies, by Platform Type, Through 2030

Table 66 : Chinese Market for Proteomic Technologies, by Application Type, Through 2030

Table 67 : Chinese Market for Proteomic Technologies, by Product Type, Through 2030

Table 68 : Japanese Market for Proteomic Technologies, by Platform Type, Through 2030

Table 69 : Japanese Market for Proteomic Technologies, by Application Type, Through 2030

Table 70 : Japanese Market for Proteomic Technologies, by Product Type, Through 2030

Table 71 : Indian Market for Proteomic Technologies, by Platform Type, Through 2030

Table 72 : Indian Market for Proteomic Technologies, by Application Type, Through 2030

Table 73 : Indian Market for Proteomic Technologies, by Product Type, Through 2030

Table 74 : South Korean Market for Proteomic Technologies, by Platform Type, Through 2030

Table 75 : South Korean Market for Proteomic Technologies, by Application Type, Through 2030

Table 76 : South Korean Market for Proteomic Technologies, by Product Type, Through 2030

Table 77 : Australian Market for Proteomic Technologies, by Platform Type, Through 2030

Table 78 : Australian Market for Proteomic Technologies, by Application Type, Through 2030

Table 79 : Australian Market for Proteomic Technologies, by Product Type, Through 2030

Table 80 : Rest of Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030

Table 81 : Rest of Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030

Table 82 : Rest of Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030

Table 83 : RoW Market for Proteomic Technologies, by Platform Type, Through 2030

Table 84 : RoW Market for Proteomic Technologies, by Application Type, Through 2030

Table 85 : RoW Market for Biochips, by Type, Through 2030

Table 86 : RoW Market for Proteomic Technologies, by Product Type, Through 2030

Table 87 : RoW Market for Proteomic Technologies, by Sub-region, Through 2030

Table 88 : Rank of Manufacturers in the Proteomics Technology Market, 2024

Table 89 : Mergers and Acquisitions in the Proteomics Technology Industry, 2020–2025

Table 90 : Agreements, Collaborations and Partnerships in the Proteomics Technology Industry, 2022–2025

Table 91 : Product Introductions in the Proteomics Technology Market, 2023–2025

Table 92 : Environmental Performance Initiatives in the Proteomics Industry

Table 93 : Social Performance Initiatives in Proteomics Market

Table 94 : Governance Performance Initiatives in the Proteomics Industry

Table 95 : ESG Rankings for Proteomics Companies, 2025*

Table 96 : Information Sources for this Report

Table 97 : Abbreviations Used in this Report

Table 98 : Agilent Technologies Inc.: Company Snapshot

Table 99 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024

Table 100 : Agilent Technologies Inc.: Product Portfolio

Table 101 : Agilent Technologies Inc: News/Key Developments, 2023 and 2024

Table 102 : Arrayit Corp.: Company Snapshot

Table 103 : Arrayit Corp.: Product Portfolio

Table 104 : Bio-Rad Laboratories Inc.: Company Snapshot

Table 105 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024

Table 106 : Bio-Rad Laboratories Inc.: Product Portfolio

Table 107 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021 and 2023

Table 108 : Bio-Techne: Company Snapshot

Table 109 : Bio-Techne: Financial Performance, FY 2022 and 2023

Table 110 : Bio-Techne: Product Portfolio

Table 111 : Bio-Techne: News/Key Developments, 2024 and 2025

Table 112 : Bruker: Company Snapshot

Table 113 : Bruker: Financial Performance, FY 2023 and 2024

Table 114 : Bruker: Product Portfolio

Table 115 : Bruker: News/Key Developments, 2022–2025

Table 116 : Creative Proteomics: Company Snapshot

Table 117 : Creative Proteomics: Product Portfolio

Table 118 : Danaher Corp.: Company Snapshot

Table 119 : Danaher Corp.: Financial Performance, FY 2023 and 2024

Table 120 : Danaher Corp.: Product Portfolio

Table 121 : Danaher Corp.: News/Key Developments, 2024

Table 122 : JEOL Ltd.: Company Snapshot

Table 123 : JEOL Ltd.: Financial Performance, FY 2022 and 2023

Table 124 : JEOL Ltd.: Product Portfolio

Table 125 : JEOL Ltd.: News/Key Developments, 2023

Table 126 : Merck KGaA: Company Snapshot

Table 127 : Merck KGaA: Financial Performance, FY 2023 and 2024

Table 128 : Merck KGaA: Product Portfolio

Table 129 : Merck KGaA: News/Key Developments, 2023 and 2024

Table 130 : Promega Corp.: Company Snapshot

Table 131 : Promega Corp.: Product Portfolio

Table 132 : Revvity: Company Snapshot

Table 133 : Revvity: Financial Performance, FY 2023 and 2024

Table 134 : Revvity: Product Portfolio

Table 135 : Revvity: News/Key Developments, 2023 and 2024

Table 136 : Shimadzu Corp.: Company Snapshot

Table 137 : Shimadzu Corp.: Financial Performance, FY 2022 and 2023

Table 138 : Shimadzu Corp.: Product Portfolio

Table 139 : Shimadzu Corp.: News/Key Developments, 2024 and 2025

Table 140 : Standard BioTools: Company Snapshot

Table 141 : Standard BioTools: Financial Performance, FY 2023 and 2024

Table 142 : Standard BioTools: Product Portfolio

Table 143 : Standard BioTools: News/Key Developments, 2024

Table 144 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 145 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024

Table 146 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 147 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022–2025

Table 148 : Waters Corp.: Company Snapshot

Table 149 : Waters Corp.: Financial Performance, FY 2023 and 2024

Table 150 : Waters Corp.: Product Portfolio

Table 151 : Waters Corp.: News/Key Developments, 2023 and 2024

Table 152 : Emerging Startups in the Global Proteomics Market

List of Figures

Summary Figure : Share of Global Market for Proteomic Technologies, by Region, 2024

Figure 1 : Bottom-Up and Top-Down Proteomics

Figure 2 : Porter’s Five Forces Analysis of the Market for Proteomic Technologies

Figure 3 : Market Dynamics for Proteomics Technologies

Figure 4 : Average Venture Funding for Biopharma Therapeutics and Platform Companies, 2010–2024

Figure 5 : Pharmaceutical R&D Expenditures for the U.S., Europe, Japan and China, for 2010, 2020 and 2022

Figure 6 : Personalized Medicines and All FDA Approvals, 2015–2023

Figure 7 : Patents Related to Proteomics, by Applicant, 2021–March 2025

Figure 8 : Share of Patents Related to Proteomics, by Country/Region, 2021–March 2025

Figure 9 : Patents Related to Proteomics, by Year, 2010–March 2025

Figure 10 : Share of Global Market for Proteomics Technologies, by Platform Type, 2024

Figure 11 : Share of Global Market for Proteomics Technologies, by Application Type, 2024

Figure 12 : Share of Global Market for Proteomics Technologies, by Platform Type, 2024

Figure 13 : Share of Global Market for Proteomic Technologies, by Region, 2024

Figure 14 : Share of North American Market for Proteomic Technologies, by Country, 2024

Figure 15 : NIH Funding in Healthcare R&D, 2010–2023

Figure 16 : Share of European Market for Proteomic Technologies, by Country, 2024

Figure 17 : Share of Asia-Pacific Market for Proteomic Technologies, by Country, 2024

Figure 18 : Share of RoW Market for Proteomic Technologies, by Sub-region, 2024

Figure 19 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024

Figure 20 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024

Figure 21 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024

Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024

Figure 23 : Bio-Techne: Revenue Share, by Business Unit, FY 2023

Figure 24 : Bio-Techne: Revenue Share, by Country/Region, FY 2023

Figure 25 : Bruker: Revenue Share, by Business Unit, FY 2024

Figure 26 : Bruker: Revenue Share, by Country/Region, FY 2024

Figure 27 : Danaher Corp.: Revenue Share, by Business Unit, FY 2024

Figure 28 : Danaher Corp.: Revenue Share, by Country/Region, FY 2024

Figure 29 : JEOL Ltd.: Revenue Share, by Business Unit, FY 2023

Figure 30 : JEOL Ltd.: Revenue Share, by Country/Region, FY 2023

Figure 31 : Merck KGaA: Revenue Share, by Business Unit, FY 2024

Figure 32 : Merck KGaA: Revenue Share, by Country/Region, FY 2024

Figure 33 : Revvity: Revenue Share, by Business Unit, FY 2024

Figure 34 : Revvity: Revenue Share, by Country/Region, FY 2024

Figure 35 : Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023

Figure 36 : Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023

Figure 37 : Standard BioTools: Revenue Share, by Business Unit, FY 2024

Figure 38 : Standard BioTools: Revenue Share, by Country/Region, FY 2024

Figure 39 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024

Figure 40 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024

Figure 41 : Waters Corp.: Revenue Share, by Business Unit, FY 2024

Figure 42 : Waters Corp.: Revenue Share, by Country/Region, FY 2024